Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

News > All

Total search results: 1537 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge. 2019-12-10
BC Platforms. (12/6/19). "Press Release: BC Platforms Partners with Leading European Genomics Service Provider Center Life & Brain to Expand Genotyping Services Across Europe". Zürich & Boston, MA. 2019-12-06
Unibio International plc. (12/4/19). "Press Release: Mitsubishi Corporation Invests in, and Partners with, Unibio". London & Copenhagen. 2019-12-04
BRAIN AG. (12/2/19). "Press Release: New Chairman of the Management Board – Adriaan Moelker Takes Over from Dr Jürgen Eck". Zwingenberg. 2019-12-02
Oncopeptides AB. (12/2/19). "Press Release: Oncopeptides Appoints Joseph Horvat as President North America". Stockholm. 2019-12-02
European Invesmtent Bank (EIB). (11/29/19). "Press Release: A European Fund to Support the Circular Bioeconomy". 2019-11-29
Avantium N.V.. (11/28/19). "Press Release: Avantium Secures Financing Milestone with €25 million EU Funding for FDCA Flagship Plant". Amsterdam. 2019-11-28
Novo Holdings A/S. (11/26/19). "Press Release: Novo Seeds Expands Company Formation Activities at BiOrigin with Seasoned Entrepreneurs". Copenhagen. 2019-11-26
Asahi Kasei Corporation. (11/25/19). "Press Release: Asahi Kasei to Acquire Veloxis Pharmaceuticals Inc. to Accelerate Transformation into a Global Health Care Company". Tokyo. 2019-11-25
GeNeuro S.A.. (11/25/19). "Press Release: GeNeuro and the Karolinska Institutet/Academic Specialist Center of Stockholm Agree to Launch a New Clinical Study of Temelimab in Multiple Sclerosis". Geneva. 2019-11-25
Ferring Pharmaceuticals S.A.. (11/25/19). "Press Release: Ferring and Blackstone Life Sciences Invest over $570 Million USD in Novel Gene Therapy for Bladder Cancer Patients". Saint-Prex & Cambridge, MA. 2019-11-25
Asahi Kasei Corporation. (11/25/19). "Press Release: Presentation – Accelerating Transformation into a Global Health Care Company. Acquisition of U.S.-based Veloxis Pharmaceuticals Inc.". Tokyo. 2019-11-25
Veloxis Pharmaceuticals A/S. (11/25/19). "Press Release: Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis [Not for any jurisdiction where violation of law]". Copenhagen. 2019-11-25
Novo Holdings A/S. (11/19/19). "Press Release: Novo Ventures and Broad Institute of MIT and Harvard Launch Drug Discovery »Greenhouse« to Drive Creation of Innovative New Therapies". Boston, MA. 2019-11-19
Zelluna Immunotherapy AS. (11/19/19). "Press Release: Zelluna Immunotherapy and Glycostem Therapeutics Announce Partnership to Develop Allogeneic TCR-NK Therapies". Oslo & Oss. 2019-11-19
Novo Nordisk A/S. (11/18/19). "Press Release: Dicerna and Novo Nordisk Enter Agreement to Discover and Develop RNAi Therapies for Liver-related Cardio-metabolic Diseases". Lexington, MA & Bagsvaerd. 2019-11-18
Fujifilm Corporation. (11/14/19). "Press Release: Fujifilm Announces Expansion of its Biopharmaceutical Contract Development and Manufacturing Business". Tokyo. 2019-11-14
Bavarian Nordic A/S. (11/13/19). "Press Release: Bavarian Nordic Announces Appointment of Jean-Christophe May as Executive Vice President and Chief Commercial Officer". Copenhagen. 2019-11-13
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
BC Platforms. (11/7/19). "Press Release: BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine". Zürich & Boston, MA. 2019-11-07
Zelluna Immunotherapy AS. (11/4/19). "Press Release: Zelluna Immunotherapy Appoints Dr Bent Jakobsen, a Pioneer of TCR Therapeutics, to the Board of Directors". Oslo. 2019-11-04
Mesa Laboratories, Inc.. (10/31/19). "Press Release: Mesa Labs Acquires Gyros Protein Technologies". Lakewood, CO. 2019-10-31
Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA. 2019-10-29
Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. 2019-10-29
Disc Medicine. (10/29/19). "Press Release: Disc Medicine Expands Pipeline Focused on Hepcidin Pathway. Enters into Exclusive Agreement with AbbVie for Series of Hemojuvelin Antagonist Monoclonal Antibodies". Cambridge, MA. 2019-10-29
H. Lundbeck A/S. (10/22/19). "Press Release: Lundbeck Completes the Acquisition of Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention". Valby. 2019-10-22
Zealand Pharma A/S. (10/22/19). "Press Release: Zealand Pharma Expands Its Peptide Platform with Acquisition of Encycle Therapeutics". Copenhagen. 2019-10-22
Cision Ltd.. (10/22/19). "Press Release: Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion". Chicago. 2019-10-22
Bavarian Nordic A/S. (10/21/19). "Press Release: Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline". Copenhagen. 2019-10-21
BC Platforms. (10/17/19). "Press Release: BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases". Zürich & Boston, MA. 2019-10-17
Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris. 2019-10-17
Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. 2019-10-16
Bluebird Bio, Inc.. (10/9/19). "Press Release: Bluebird Bio and Novo Nordisk Enter into Research Agreement to Develop in vivo Genome Editing Candidates for Haemophilia and Other Severe Genetic Diseases". Cambridge, MA & Bagsvaerd. 2019-10-09
Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). 2019-10-08
4SC AG. (10/7/19). "Press Release: 4SC AG Resolves to Issue New Shares, Santo and ATS Undertake to Subscribe / Buy the New Shares [Not for US, AU, CA, et al.]". Planegg-Martinsried. 2019-10-07
LeadXPro AG. (10/7/19). "Press Release: LeadXPro and Lundbeck enter Strategic Partnership on Membrane Protein Structure Research". Villigen. 2019-10-07
Blueprint Genetics Oy. (10/2/19). "Press Release: Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness Launch an Open Access Program for Patients with Inherited Retinal Disease in the United States". 2019-10-02
Arix Bioscience plc. (9/30/19). "Press Release: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics". London. 2019-09-30
Zealand Pharma A/S. (9/24/19). "Press Release: Zealand Pharma Achieves Primary and All Key Secondary Endpoints in Pediatric Phase 3 Trial with Dasiglucagon for Severe Hypoglycemia". Copenhagen. 2019-09-24
Blueprint Genetics Oy. (9/24/19). "Press Release: Blueprint Genetics and ArchimedLife Form a Partnership to Launch High Quality Biochemical Testing for Rare Diseases in North America". 2019-09-24
H. Lundbeck A/S. (9/20/19). "Press Release: Lundbeck and Takeda Announce Ministry of Health, Labour and Welfare (MHLW) Approval of Trintellix in Japan". 2019-09-20
Themis Bioscience GmbH. (9/18/19). "Press Release: Themis Raises EUR 40 Million in Series D Financing Round Backed by US/EU Consortium to Support Pivotal Study and Expand Clinical Pipeline". Vienna. 2019-09-18
Amra Medical AB. (9/17/19). "Press Release: Amra Medical Welcomes Jonas Lindqvist to the Team as Director of Operations as It Strengthens Its Delivery Capabilities in Clinical Trials". Linköping. 2019-09-17
H. Lundbeck A/S. (9/16/19). "Press Release: Lundbeck to Acquire Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention – in a Transaction Valued at up to USD 1.95 Billion Net of Cash". Valby & Bothell, WA. 2019-09-16
Lytix Biopharma AS. (9/12/19). "Press Release: Lytix Biopharma AS Appoints Øystein Rekdal as the new CEO". 2019-09-12
Genedata AG. (9/11/19). "Press Release: Orion Pharmaceuticals Implements Genedata Biologics to Support New Large-Molecule R&D Initiative". Basel. 2019-09-11
Amra Medical AB. (9/10/19). "Press Release: Amra Announces Strategic Partnership with Japanese Leading Imaging CRO, Micron, Inc., to Support Clinical Trials in Japan". Linköping. 2019-09-10
Genmab A/S. (9/9/19). "Press Release: Genmab and Tempus Enter into Strategic Collaboration Agreement". Copenhagen. 2019-09-09
Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to 2019-09-05
Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen. 2019-09-04
Boehringer Ingelheim. (9/3/19). "Press Release: Boehringer Ingelheim and Zealand Pharma Advance Dual-Acting GLP-1/Glucagon Agonist BI 456906 to Phase 2 Clinical Testing in Obesity/Diabetes". Ingelheim & Copenhagen. 2019-09-03
RhoVac AB. (9/2/19). "Press Release: RhoVac Optimizes the Structure of the Management Team and Appoints Anders Månsson as New CEO". 2019-09-02
Novartis AG. (8/30/19). "Press Release: Novartis Ofatumumab Demonstrates Superiority versus Aubagio in Two Head-to-head Phase III Multiple Sclerosis Studies". Basel. 2019-08-30
Unibio International plc. (8/28/19). "Press Release: Unibio Completes USD 15 M (GBP 12.4 M) Financing Round". London & Copenhagen. 2019-08-28
Nanovi A/S. (8/27/19). "Press Release: Nanovi Raises New Capital". Copenhagen. 2019-08-27
RhoVac AB. (8/22/19). "Press Release: RhoVac AB Has Been Granted 2.5 Million Euro from Horizon 2020". 2019-08-22
AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi". 2019-08-22
Alligator Bioscience AB. (8/20/19). "Press Release: Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.". Lund. 2019-08-20
H. Lundbeck A/S. (8/14/19). "Press Release: Lundbeck Appoints New EVP, People & Communication". Valby. 2019-08-14
Novozymes A/S. (8/8/19). "Press Release: Change to the Executive Leadership Team". Bagsvaerd. 2019-08-08
High-Tech Gründerfonds Management GmbH. (8/8/19). "Press Release: Successful Exit for High-Tech Gründerfonds (HTGF) – HTGF sells Its Cytena Shares to Cellink in a Trade Sale". 2019-08-08
Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. 2019-08-05
Cytena GmbH. (8/5/19). "Press Release: Cytena GmbH Announces that It Has Been Entered into an Agreement to Be Acquired by Cellink". Freiburg. 2019-08-05
ExpreS2ion Biotech Holding AB. (8/2/19). "Press Release: ExpreS2ion’s Licensee Institut Virion\Serion Launches the First in Vitro Diagnostic Product Based on the ExpreS2-platform". 2019-08-02
Alligator Bioscience AB. (7/31/19). "Press Release: Alligator Bioscience Regains Global Rights from Janssen to CD40 Agonistic Antibody, ADC-1013 (JNJ-64457107)". Lund. 2019-07-31
Bayer AG. (7/31/19). "Press Release: U.S. FDA Approves Darolutamide, a New Treatment for Men with Non-metastatic Castration-resistant Prostate Cancer [Not intended for U.S. and UK Media]". Berlin. 2019-07-31
NEC Corporation. (7/29/19). "Press Release: NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS". Tokyo. 2019-07-29
Cytena GmbH. (7/23/19). "Press Release: Cytena Founds Subsidiary in Taiwan". Freiburg. 2019-07-23
Genmab A/S. (7/19/19). "Press Release: Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering". Copenhagen. 2019-07-19
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. 2019-07-19
Genmab A/S. (7/12/19). "Press Release: Genmab and Blink Biomedical Enter into Commercial License Agreement". Copenhagen. 2019-07-12
Nanoform Finland Ltd.. (7/10/19). "Press Release: Nanoform Appoints Director of Investor Relations Following International Growth". Helsinki. 2019-07-10
Genedata AG. (7/9/19). "Press Release: Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations". Basel. 2019-07-09
IGM Biosciences, Inc.. (7/8/19). "Press Release: IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline". 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
Cobo Technologies ApS. (7/5/19). "Press Release: CRISPR Researchers to Benefit from Cobo Technologies and Sciex Partnership". Copenhagen. 2019-07-05
Nanoform Finland Ltd.. (7/3/19). "Press Release: Nanoform Continues Strategic Growth with €10 Million Private Placement". Helsinki. 2019-07-03
Bayer AG. (7/2/19). "Press Release: Leo Pharma Completes the Acquisition of Bayer’s Prescription Dermatology Business". Ballerup & Leverkusen. 2019-07-02
Photocure ASA. (7/1/19). "Press Release: Photocure and Asieris Enter into a Global Licensing Deal for Cevira with up to USD 250 Million in Milestones and Double-digit Royalties". Oslo. 2019-07-01
ExpreS2ion Biotech Holding AB. (7/1/19). "Press Release: ExpreS2ion Licenses Groundbreaking CRISPR/Cas9 Gene Editing Technology from ERS Genomics". 2019-07-01
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
Oncopeptides AB. (6/28/19). "Press Release: Oncopeptides Has Completed a Directed Share Issue of approximately SEK 727 Million (USD 78 M) [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]". 2019-06-28
Storm Therapeutics Ltd.. (6/27/19). "Press Release: Storm Therapeutics Appoints Dr John Haurum to the Board of Directors". Cambridge. 2019-06-27
Oncopeptides AB. (6/27/19). "Press Release: Oncopeptides Intends to Make a Directed Share Issue [Not for USA, CA, IL, JP, ZA or AU or any other jurisdiction where unlawful]". 2019-06-27
Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. 2019-06-26
Quanterix Corporation. (6/26/19). "Press Release: Quanterix Announces Agreement to Acquire UmanDiagnostics, World’s Leading Neurofilament Light (Nf-L) Antibody Supplier". Billerica, MA. 2019-06-26
Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. 2019-06-25
Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. 2019-06-25
MGI Tech Co., Ltd.. (6/20/19). "Press Release: MGI Forms Partnership with Karolinska Institutet Centre for Translational Microbiome Research (CTMR) to Understand the Effects of Microbiome on Human Health". Shenzhen. 2019-06-20
Genovis AB. (6/19/19). "Press Release: Genovis AB Hires CFO". 2019-06-19
Spero Therapeutics, Inc.. (6/13/19). "Press Release: Spero Announces $10 Million Registered Direct Offering of Common Stock. Novo Holdings A/S through Its Novo REPAIR Impact Fund to Invest Up to $10 million". Cambridge, MA. 2019-06-13
Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo. 2019-06-11
Genmab A/S. (6/11/19). "Press Release: Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38". Copenhagen. 2019-06-11
Sprint Bioscience AB. (6/11/19). "Press Release: Sprint Bioscience Appoints Jessica Martinsson as Acting CEO after CEO Anders Åberg Announces His Resignation". 2019-06-11
Agilent Technologies Inc.. (6/11/19). "Press Release: Agilent Companion Diagnostic Gains Expanded FDA Approval in Head and Neck Squamous Cell Carcinoma (HNSCC)". Santa Clara, CA. 2019-06-11
Lunaphore Technologies S.A.. (6/10/19). "Press Release: Cartana, Lunaphore and Stockholm University Collaborate on Automated Next Generation In Situ Sequencing". Stockholm & Lausanne. 2019-06-10
Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore". 2019-06-10
Themis Bioscience GmbH. (6/4/19). "Press Release: CEPI Awards up to US$21 Million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development". Vienna & Oslo. 2019-06-04
Biotage AB. (6/4/19). "Press Release: Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications". Uppsala. 2019-06-04
Leo Pharma A/S. (6/3/19). "Press Release: Leo Pharma Appoints Catherine Mazzacco as New CEO". Ballerup. 2019-06-03
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

» top